Trial Profile
Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics; Registrational
- Sponsors Intercell
- 09 Jun 2010 Results of the long-term follow-up study reported in Vaccine.
- 01 Mar 2009 Results published in Vaccine 27: 2188-2193, No. 15, 26 Mar 2009